🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Evaluate the efficacy and safety of Anlotinib plus Icotinib as the first-li...
Status
Completed
Location
Hebei Provincial People's Hospital
Start Date
2018-12-01
Trial ID
NCT03736837
Treatments Being Tested
A single arm study: EGFR-TKIs Combine With Anlotinib as First-line Treatmen...
Status
Unknown
Location
Fujian cancer hospital
Start Date
2018-10
Trial ID
NCT03720873
Treatments Being Tested
The Single-arm, multicenter study evaluate the safety and efficacy of Anlot...
Status
Unknown
Location
Guangdong General Hospital
Start Date
2019-07
Trial ID
NCT04007835
Treatments Being Tested
After the second-line treatment of patients with non-T790M mutations, chemo...
Status
Unknown
Location
The First Affiliated hospital of soochow university
Start Date
2019-03-30
Trial ID
NCT03766490
Treatments Being Tested
Evaluate the efficacy and safety of Anlotinib plus Icotinib as the first-li...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-03-12
Trial ID
NCT04797806